cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Instil Bio Inc
12 own
9 watching
Current Price
$0.89
$0
(-0.16%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
115.51M
52-Week High
52-Week High
13.01
52-Week Low
52-Week Low
0.471
Average Volume
Average Volume
0.88M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
28
iconMarket Capitalization115.51M
icon52-Week High13.01
icon52-Week Low0.471
iconAverage Volume0.88M
iconDividend Yield--
iconP/E Ratio28
What does the Instil Bio Inc do?
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.
Read More
How much money does Instil Bio Inc make?
News & Events about Instil Bio Inc.
Globe Newswire
26days ago
Phase 1 trial of ITIL-306 in NSCLC, ovarian, and RCC re-opened to enrollment after voluntary pause Initial data readout for ITIL-306 expected in 2023 With recent reprioritization of clinical programs and corporate restructuring, company expects cash runway into 2025, excluding potential financing or...
Globe Newswire
1month ago
NEW YORK, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Instil Bio, Inc. (Instil Bio or the Company) (NASDAQ: TIL) on behalf of Instil Bio stockholders. Our investigation concerns whether ...
Market News Video
1month ago
In trading on Wednesday, biotechnology shares were relative leaders, up on the day by about 0.4%. Leading the group were shares of Instil Bio, up about 19.7% and shares of Relmada Therapeutics up about 17.4% on the day...
Globe Newswire
1month ago
NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against PROG Holdings, Inc. (NYSE: PRG), Fox Corporation (NASDAQ: FOX, FOXA), Instil Bio, Inc. (NASDAQ: TIL), and Twist Bioscience Corp (...
Business Wire
1month ago
Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Instil Bio, Inc. (NASDAQ:TIL) (Instil or the Company). The investigations concern whether certain of the Instils officers and directors breached their fiduciary duties to shareholders, by...
Frequently Asked Questions
Frequently Asked Questions
What is Instil Bio Inc share price today?
plus_minus_icon
Can Indians buy Instil Bio Inc shares?
plus_minus_icon
How can I buy Instil Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Instil Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Instil Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Instil Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Instil Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Instil Bio Inc?
plus_minus_icon
What percentage is Instil Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Instil Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.89
$0
(-0.16%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00